All articles tagged: Family history of human immunodeficiency virus [HIV] disease (Z83.0)

HIV remission in children, characterized by a sustained period of undetectable viral load without the need for antiretroviral therapy (ART), represents a significant breakthrough in pediatric HIV care. This phenomenon, observed in children who have undergone a pause in treatment, offers new insights into the management and potential cure of HIV/AIDS.

Researchers are optimistic about developing an effective HIV vaccine after decades of setbacks. Recent advancements in understanding immune responses offer renewed hope. New vaccine candidates are showing promising results in early trials, sparking optimism for future HIV prevention strategies.

Pediatric HIV remission, marked by prolonged undetectable viral load sans antiretroviral therapy (ART), is a notable advance. This condition, seen in children with treatment pauses, offers fresh perspectives on HIV/AIDS management and potential cure.

Duke researchers have identified a key moment in HIV infection, where the virus's envelope glycoprotein opens to attach to T-cells. This discovery offers new directions for AIDS vaccine development, focusing on antibodies that block this process, and marks a significant shift in understanding HIV's infection mechanism.

Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.Michael J. Silverberg, Ph.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues conducted a retrosp

An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adj

An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adj

In what could prove to be a major turning point for the prescription drug market in the United States, the U.S. Food and Drug Administration has approved a Florida plan to import drugs from Canada.U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purcha

For Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline postexposure prophylaxis (PEP) compared with standard care, according to a study published in the Dec. 21 issue of the New England Journal of Medicine.Jenell Stewart, D

From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published online Dec. 19 in the Annals of Internal Medicine.Ya-Lin A. Huang, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estim

For neonates with in utero HIV-1, very early antiretroviral therapy (ART) can achieve sustained virological suppression, according to a study published online Dec. 4 in The Lancet HIV.Deborah Persaud, M.D., from Johns Hopkins University School of Medicine in Baltimore, and colleagues enrolled infants at 30 research clinics in 11 countr

More infants and children aged younger than 5 years with HIV receiving antiretroviral therapy (ART) die compared with those aged 5 years and older receiving ART, according to research published in the Dec. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Nickolas T. Agathis, M.D., fr

Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to a study published online Nov. 28 in the Annals of Internal Medicine.Niraj M. Desai, M.D., from the Johns Hopkins Univ

One-quarter of young sexual and gender minorities (YSGM) have syphilis at some point in their lives, according to a study published online Oct. 10 in the Journal of Infectious Diseases.Casey D. Xavier Hall, M.P.H., Ph.D., from Florida State University in Tallahassee, and colleagues examined syphilis incidence and prevalence prospect